ONABOTULINUMTOXINA IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER WITH URINARY INCONTINENCE

被引：0
|
作者：
Sand, P. K. [1 ]
Khalaf, K. M. [2 ]
Yan, X. [2 ]
Globe, D. [2 ]
机构：
[1] Univ Chicago, Evanston Continence Ctr, Evanston, IL USA
[2] Allergan Pharmaceut Inc, Irvine, CA USA
来源：
INTERNATIONAL UROGYNECOLOGY JOURNAL | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
138
引用
收藏
页码：S191 / S192
页数：2
相关论文
共 50 条
  • [21] ONABOTULINUMTOXINA REDUCES NOCTURNAL VOIDS AND IMPROVES QUALITY OF LIFE IN OVERACTIVE BLADDER PATIENTS WITH NOCTURIA
    Dmochowski, R.
    Ginsberg, D.
    Parsons, M.
    Robinson, D.
    Magyar, A.
    Nicandro, J.
    Drake, M.
    [J]. NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S107 - S107
  • [22] The impact of the overactive bladder on health-related utility and quality of life
    Currie, Craig J.
    McEwan, Phil
    Poole, Chris D.
    Odeyemi, Isaac A. O.
    Datta, Shibendra N.
    Morgan, Christopher L.
    [J]. BJU INTERNATIONAL, 2006, 97 (06) : 1267 - 1272
  • [23] ONABOTULINUMTOXINA SIGNIFICANTLY IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME: A POOLED ANALYSIS OF 2 PHASE 3 PLACEBO-CONTROLLED TRIALS
    Sussman, David
    Egerdie, Blair
    Zhou, Jihao
    Khalaf, Kristin
    Nardo, Christopher
    Sand, Peter
    [J]. NEUROUROLOGY AND URODYNAMICS, 2014, 33 (02) : 208 - 209
  • [24] OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
    Chapple, Christopher
    Sievert, Karl-Dietrich
    MacDiarmid, Scott
    Khullar, Vik
    Radziszewski, Piotr
    Nardo, Christopher
    Thompson, Catherine
    Zhou, Jihao
    Haag-Molkenteller, Cornelia
    [J]. EUROPEAN UROLOGY, 2013, 64 (02) : 249 - 256
  • [25] Economic impact of onabotulinumtoxinA for overactive bladder with urinary incontinence in Europe
    Ruff, Lewis
    Bagshaw, Emma
    Aracil, Javier
    Velard, Marie-Eve
    Pardhanani, Gianni
    Hepp, Zsolt
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (12) : 1107 - 1115
  • [26] EARLY AND CONSISTENT IMPROVEMENTS IN QUALITY OF LIFE AND URINARY SYMPTOMS WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    McCammon, Kurt
    Gousse, Angelo
    Gruenenfelder, Jennifer
    Hale, Douglass
    Orejudos, Amelia
    Aboushwareb, Tamer
    Kohan, Alfred
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S578 - S579
  • [27] EARLY AND CONSISTENT IMPROVEMENTS IN QUALITY OF LIFE AND URINARY SYMPTOMS WITH ONABOTULINUMTOXINA IN OVERACTIVE BLADDER PATIENTS WITH URINARY INCONTINENCE IN A RANDOMIZED, PLACEBO-CONTROLLED TRIAL
    McCammon, Kurt
    Gousse, Angelo
    Gruenenfelder, Jennifer
    Hale, Douglass
    Orejudos, Amelia
    Aboushwareb, Tamer
    Kohan, Alfred
    [J]. JOURNAL OF UROLOGY, 2018, 199 (04): : E351 - E351
  • [28] Health-related quality of life in patients with neurogenic vs. idiopathic overactive bladder
    Burks, J.
    Kennelly, M.
    Rovner, E.
    Signori, M.
    Globe, D.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S253 - S254
  • [29] Health-related quality of life in patients with overactive bladder: Results from the ABLE study
    Chancellor, Michael B.
    Aronstein, William S.
    Kianifard, Farid
    Ebinger, Ursula
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2007, 14 (06): : 1093 - 1093
  • [30] ELICITATION OF HEALTH-RELATED QUALITY OF LIFE CONCEPTS ASSOCIATED WITH OVERACTIVE BLADDER
    Hawken, N. A.
    Aballea, S.
    Hakimi, Z.
    Nazir, J.
    Odeyemi, I. A.
    Toumi, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A635 - A635
12345